Biden’s price fixing will slow pharmaceutical investment, delaying Americans’ access to life-saving treatments. Indeed, a meta-analysis from the Information Technology and Innovation Foundation reports, “Academic studies consistently show that a reduction in current drug revenues leads to a fall in future research and the number of new drug discoveries.”
